Pub. Date : 2020 Sep 30
PMID : 32839355
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up. | ferric carboxymaltose | erythropoietin | Homo sapiens |
| 2 | The monthly dose of EPO was reduced in the FCM period (-6,404.1 international unit [IU]; 95% confidence interval, -10,643.5 IU; -2,164.6 IU; P = 0.003), as well as the erythropoietin resistance index (P = 0.004). | ferric carboxymaltose | erythropoietin | Homo sapiens |
| 3 | The monthly dose of EPO was reduced in the FCM period (-6,404.1 international unit [IU]; 95% confidence interval, -10,643.5 IU; -2,164.6 IU; P = 0.003), as well as the erythropoietin resistance index (P = 0.004). | ferric carboxymaltose | erythropoietin | Homo sapiens |
| 4 | Conclusion: During FCM treatment, minor doses of EPO were administered if compared to those delivered during FX therapy. | ferric carboxymaltose | erythropoietin | Homo sapiens |